TRBC2 and acute lymphoblastic leukemia: To test the efficacy of CAR-T cells in mouse models of T cell malignancies, NSG mice were intravenously injected with Jurkat (TRBC1+ or TRBC2+) and HPB-ALL (TRBC2+) T cells, modified to express firefly luciferase (FLuc).